TAMMY EASTERLY: Open Payments
NPI 1649768805 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,415 in 59 payments from 32 companies in 2025. Trend: 2023 $1,321 · 2024 $1,924 · 2025 $1,415
Food & beverage: $1,415
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $155 |
| AstraZeneca Pharmaceuticals LP | 6 | $151 |
| Novartis Pharmaceuticals Corporation | 5 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $118 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| Celgene Corporation | 3 | $67 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $51 |
| ABBVIE INC. | 2 | $47 |
| GENZYME CORPORATION | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
Products named: Enhertu, LIBTAYO, KISQALI, KEYTRUDA, OPDIVO, ZYNLONTA, EPKINLY, LYNPARZA.
Industry payments across TN — which companies pay providers there.
